Epstein Secrets

Will Continue To Get In-Person Briefings. Politico <https://www.politico.com/news/2020/09/02/rubio-intel-election-briefing-ratcliffe-407755> (9/2, Desiderio, 4.29M) reports that Acting SSCI Chair Marco Rubio said Wednesday that the panel will "continue to receive in-person briefings from top U.S. intelli

escent Plasma. In an op-ed for the New York Times <https://www.nytimes.corn/2020/09/02/opinion/coronavirus-convalescent-plasma.html> (9/2, 18.61M), Daniela J. Lamas, a critical care doctor, questions the Food and Drug Administration's "emergency use authorization for convalescent plasma despite inadequate eviden

eparate position with a Chinese company, all while working on NASA research." Rubio: SSCI Will Continue To Get In-Person Briefings. Politico (9/2, Desiderio, 4.29M) reports that Acting SSCI Chair Marco Rubio said Wednesday that the panel will "continue to receive in-person briefings from top U.S. intelli

initive answer." Lamas: Insufficient Clinical Data For Efficacy Or Safety Of Convalescent Plasma. In an op-ed for the New York Times (9/2, 18.61M), Daniela J. Lamas, a critical care doctor, questions the Food and Drug Administration's "emergency use authorization for convalescent plasma despite inadequate evide

eparate position with a Chinese company, all while working on NASA research." Rubio: SSCI Will Continue To Get In-Person Briefings. Politico (9/2, Desiderio, 4.29M) reports that Acting SSCI Chair Marco Rubio said Wednesday that the panel will "continue to receive in-person briefings from top U.S. intelli

initive answer." Lamas: Insufficient Clinical Data For Efficacy Or Safety Of Convalescent Plasma. In an op-ed for the New York Times (9/2, 18.61M), Daniela J. Lamas, a critical care doctor, questions the Food and Drug Administration's "emergency use authorization for convalescent plasma despite inadequate evide